Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and …
C Klipping, J Marr - Contraception, 2005 - Elsevier
OBJECTIVE: To compare the effect of ethinyl estradiol 20 μg/drospirenone 3 mg (EE 20
μg/DRSP 3 mg) administered according to a 24/4 regimen with ethinyl estradiol 20 …
μg/DRSP 3 mg) administered according to a 24/4 regimen with ethinyl estradiol 20 …
Effects of two combined oral contraceptives containing ethinyl estradiol 30 μg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles …
R Yildizhan, B Yildizhan, E Adali, P Yoruk… - Archives of gynecology …, 2009 - Springer
Objective The aim of this study is to compare the effect of ethinyl estradiol 0.03
mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg …
mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg …
A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism …
U Gaspard, J Endrikat, JP Desager, C Buicu… - Contraception, 2004 - Elsevier
In this open-label, randomized study we compared the influence of a new oral contraceptive
containing 30 μg ethinylestradiol and 3 mg drospirenone (EE+ DRSP= Yasmin™), with a …
containing 30 μg ethinylestradiol and 3 mg drospirenone (EE+ DRSP= Yasmin™), with a …
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on …
U Gaspard, A Scheen, J Endrikat, C Buicu, P Lefebvre… - Contraception, 2003 - Elsevier
In this open-label, randomized study we compared the influence of a new oral contraceptive
containing 30 μg ethinylestradiol and 3 mg drospirenone (Yasmin™) with a reference …
containing 30 μg ethinylestradiol and 3 mg drospirenone (Yasmin™) with a reference …
Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles
RB Machado, NR de Melo, H Maia Jr, AM Cruz - Contraception, 2010 - Elsevier
BACKGROUND: The objective of this study was to evaluate the effects of a contraceptive pill
containing ethinylestradiol (30 mcg) and drospirenone (3 mg) in a continuous regimen on …
containing ethinylestradiol (30 mcg) and drospirenone (3 mg) in a continuous regimen on …
[HTML][HTML] Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone
C Klipping, I Duijkers, M Mawet, C Maillard, A Bastidas… - Contraception, 2021 - Elsevier
Objectives To evaluate the effect on endocrine and metabolic parameters of a new
combined oral contraceptive (COC) containing estetrol (E4) and drospirenone (DRSP) …
combined oral contraceptive (COC) containing estetrol (E4) and drospirenone (DRSP) …
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 μg ethinylestradiol and 150 μg …
W Suthipongse, S Taneepanichskul - Contraception, 2004 - Elsevier
This study was conducted to compare the cycle control, efficacy and adverse events of a
new low-dose oral contraceptive pill regimen containing 3 mg drospirenone (DRSP)/30 μg …
new low-dose oral contraceptive pill regimen containing 3 mg drospirenone (DRSP)/30 μg …
Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone
J Huber, JM Foidart, W Wuttke… - … European Journal of …, 2000 - Taylor & Francis
Objective To assess the contraceptive reliability, cycle control and tolerability of a new
monophasic oral contraceptive containing 30 g ethinylestradiol plus 3 mg drospirenone …
monophasic oral contraceptive containing 30 g ethinylestradiol plus 3 mg drospirenone …
Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis of …
L Anttila, G Bachmann, L Hernádi, M Kunz… - European journal of …, 2011 - Elsevier
OBJECTIVE: To determine the contraceptive efficacy of a low-dose combined oral
contraceptive containing ethinyloestradiol (EE) 20μg/drospirenone (drsp) 3mg administered …
contraceptive containing ethinyloestradiol (EE) 20μg/drospirenone (drsp) 3mg administered …
A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or …
JM Foidart, W Wuttke, GM Bouw… - … European Journal of …, 2000 - Taylor & Francis
Objective To assess the contraceptive reliability, cycle control and tolerance of a new
monophasic oral contraceptive (Yasmin®) containing 30 μg ethinylestradiol and 3 mg …
monophasic oral contraceptive (Yasmin®) containing 30 μg ethinylestradiol and 3 mg …
相关搜索
- oral contraceptives drospirenone or desogestrel
- either drospirenone hemostatic parameters
- carbohydrate metabolism drospirenone or desogestrel
- carbohydrate metabolism hemostatic parameters
- carbohydrate metabolism oral contraceptives
- lipid profiles hemostatic parameters
- either drospirenone contraceptive reliability
- ethinylestradiol and drospirenone continuous regimen
- ethinylestradiol and drospirenone contraceptive combination
- oral contraceptives open label
- blood pressure hemostatic parameters
- either drospirenone cycle control
- either gestodene lipid profiles
- metabolic effects estetrol and drospirenone
- oral contraceptives thai women
- carbohydrate metabolism either drospirenone